Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,995 | -45,001 | -13,538 | -16,933 | -75,595 |
| Depreciation Amortization | 10,033 | 7,085 | 4,153 | 1,916 | 8,077 |
| Accounts receivable | 2,353 | 1,759 | 4,909 | -2,646 | -8,123 |
| Accounts payable and accrued liabilities | -7,107 | -6,655 | -7,416 | -1,928 | -1,526 |
| Other Working Capital | 13,160 | 17,222 | -5,464 | -5,430 | 23,283 |
| Other Operating Activity | 42,329 | 31,998 | 22,044 | 13,481 | 76,260 |
| Operating Cash Flow | $773 | $6,408 | $4,688 | $-11,540 | $22,376 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | -23 | -12 | N/A | -306 |
| Purchase Of Investment | -29,826 | -24,430 | -16,376 | N/A | -127,198 |
| Sale Of Investment | 73,275 | 57,033 | 51,546 | 34,377 | 132,667 |
| Purchase Sale Intangibles | -10,000 | -10,000 | -10,000 | N/A | N/A |
| Other Investing Activity | -10,000 | -10,000 | -10,000 | 0 | 0 |
| Investing Cash Flow | $33,403 | $22,580 | $25,158 | $34,377 | $5,163 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,444 | 8,444 | 8,444 | N/A | 25,000 |
| Debt Repayment | -8,444 | -8,444 | -8,444 | N/A | -80,000 |
| Common Stock Issued | 68 | 45 | 2 | N/A | 1,351 |
| Other Financing Activity | -10,000 | 0 | 0 | 0 | -13,418 |
| Financing Cash Flow | $-9,932 | $45 | $2 | $N/A | $-67,067 |
| Beginning Cash Position | 73,210 | 73,210 | 73,210 | 73,210 | 112,738 |
| End Cash Position | 97,454 | 102,243 | 103,058 | 96,047 | 73,210 |
| Net Cash Flow | $24,244 | $29,033 | $29,848 | $22,837 | $-39,528 |
| Free Cash Flow | |||||
| Operating Cash Flow | 773 | 6,408 | 4,688 | -11,540 | 22,376 |
| Capital Expenditure | -46 | -23 | -12 | N/A | -306 |
| Free Cash Flow | 727 | 6,385 | 4,676 | -11,540 | 22,070 |